Financial Daily from THE HINDU group of publications
Saturday, Feb 28, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements


Veronica Labs to launch ayurvedic AIDS drug soon

Our Bureau

Mumbai , Feb. 27

VERONICA Laboratories Ltd on Friday said it had started commercial production of Herbovera, its ayurvedic formulation for HIV patients.

The company expects to launch the product across the country by the second quarter of this year, by which time it would have produced its first consignment.

Meanwhile, top-end machinery for the purpose is being installed at its facility in Rabale, Navi Mumbai, the company told BSE here on Friday. With initial results of the clinical trials being encouraging, the company has embarked on multi-centric trials at various premier medical institutes throughout the country.

Further, the company points out that Herbovera has been found to nullify the loss of immunity observed in HIV positive patients, besides blunting their susceptibility to opportunistic infections.

Efforts are being made to get international patents in due course of time, it added.

More Stories on : Announcements | Alternative Medicines | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Petronet commercial operations from April


Cipla to ship AIDS drugs to Malaysia in 2 months
Goldstone Tech to hike authorised capital
Veronica Labs to launch ayurvedic AIDS drug soon
Ashok Leyland launches Ecomet LCV
Godrej Consumer seeks shareholders nod for buyback
Thomas Cook Q1 net profit up 24 pc
`Go slow' hits work at Chennai container terminal
Haldia Petrochem mulls expansion
Ford India upbeat on SUV segment
BiSS bags contracts in US market
Pfizer: Will 2004 erase bitter taste of 2003?
Thomas Cook board revamp



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line